semaglutide and heart VisualAbstract: improves symptoms in patients with failure Evaluating the Cardiovascular Benefits of

Hurtado MD, Tama E, Fansa S, et al

One important unresolved issue is the limited evidence regarding concomitant use of SGLT2 inhibitors and GLP-1 receptor agonists, a gap also acknowledged in European Society of Cardiology guidelines and Current guidelines prioritize SGLT2 inhibitors in patients with T2DM who have HF, chronic kidney disease, or elevated cardiovascular risk, while GLP-1 receptor agonists are emphasized for patients with obesity or established atherosclerotic cardiovascular disease [7]

Akilesh, S., Christianson, G

The peel of Punica granatum L

To use, wet the skin thoroughly and apply the soap until a rich lather forms